cccDNA
乙型肝炎病毒
生物
病毒学
STAT蛋白
质粒
干扰素
分子生物学
病毒
基因
乙型肝炎表面抗原
遗传学
车站3
作者
Takuto Nosaka,Tatsushi Naito,Yosuke Murata,Hidetaka Matsuda,Masahiro Ohtani,Katsushi Hiramatsu,Tsutomu Nishizawa,Hiroaki Okamoto,Yasunari Nakamoto
摘要
Abstract Aim Curing hepatitis B virus (HBV) infection requires elimination of covalently closed circular DNA (cccDNA). Interferon (IFN)‐γ has noncytolytic antiviral potential; however, elimination of cccDNA could not be achieved. To enhance the regulatory effect, we comprehensively analyzed the host factors associated with cccDNA amplification and IFN‐γ and IFN‐α effects using an in vitro HBV infection system showing various transcription levels. Methods Primary human hepatocytes were infected with HBV using genomic plasmids carrying the basic core promoter mutation A1762T/G1764A and/or the precore mutation G1896A and treated with IFN‐γ and IFN‐α. Comprehensive and functional studies involving microarray and small interfering RNA analysis revealed the host factors related to cccDNA regulation. Results The HBV infection system reproduced the HBV life cycle and showed various propagation levels. Microarray analysis revealed 53 genes correlated with the cccDNA levels. Of the 53 genes, expression of IFN‐induced protein 44‐like ( IFI44L ) was significantly upregulated by IFN‐γ and IFN‐α. The anti‐HBV effect of IFI44L is exerted regardless of IFN‐γ or IFN‐α by inhibiting the activation of nuclear factor‐κB and signal transducer and activator of transcription 1 pathways. Conclusions Using the in vitro HBV infection system, an IFN‐inducible molecule, IFI44L, associated with cccDNA amplification, was identified. These results suggest an innovative molecular strategy for the regulation of HBV cccDNA by controlling a novel host factor, IFI44L.
科研通智能强力驱动
Strongly Powered by AbleSci AI